1938
DOI: 10.1210/endo-23-6-784
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Testosterone Propionate in Functional Bleeding

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
4
0

Year Published

1940
1940
1968
1968

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 22 publications
(5 citation statements)
references
References 0 publications
1
4
0
Order By: Relevance
“…The histological changes found in the present series after administration of testosterone are the same as those described for the human subject by Geist et al [1938], who suggest that the regressive changes are the 'end results of a primary inhibition of the gonadotrophic factors of the hypo¬ physis ' with consequent failure of secretion of the ovarian hormones ; in the light of the present work on the monkey the endometrial changes may be due either to a direct action of testosterone or to its neutralization of the oestrone-in the intact animal these effects may be reinforced by pituitary inhibition. Loeser [1938] reported endometrial atrophy in a woman after testosterone therapy; Foss [1938] said that in his cases after testosterone the endometrium was of the interval type.…”
Section: Resultssupporting
confidence: 84%
See 1 more Smart Citation
“…The histological changes found in the present series after administration of testosterone are the same as those described for the human subject by Geist et al [1938], who suggest that the regressive changes are the 'end results of a primary inhibition of the gonadotrophic factors of the hypo¬ physis ' with consequent failure of secretion of the ovarian hormones ; in the light of the present work on the monkey the endometrial changes may be due either to a direct action of testosterone or to its neutralization of the oestrone-in the intact animal these effects may be reinforced by pituitary inhibition. Loeser [1938] reported endometrial atrophy in a woman after testosterone therapy; Foss [1938] said that in his cases after testosterone the endometrium was of the interval type.…”
Section: Resultssupporting
confidence: 84%
“…These considerations led to the adoption of an average dose of about 1 mg. of oestrone in oil per day ; this amount should give a good contrast with the spayed untreated group. The dosage of testosterone propionate was of the same order as that given by Geist, Salmon & Gaines [1938] to women-again a large dose should produce a change if one was forthcoming. The dosage of progesterone varied over a range, on a weight basis, from about the same as that given to women threatened with abortion to a very much greater dosage.…”
Section: Resultsmentioning
confidence: 99%
“…However, it has more recently been found that doses below the gonadotropin suppressing range are still very adequate for contraception. The effect of these compounds may therefore be on the reproductive organs rather than on the pituitary, as previously supposed.1 9 It should be noted that the administration of minimum ovulation suppressing doses is frequently complicated by breakthrough bleeding, which in turn can be prevented by the addition of small doses of estrogens. Upon the discontinuance of therapy, ovulation usually resumes promptly.…”
Section: Contraceptionmentioning
confidence: 92%
“…10 An alternative procedure involves the injection of progesterone in oil combined with testosterone, 25 mg. of each, the two being given daily over a period of 5 days.1. 9,14 The testosterone is supposed to exert a uterine hemostatic effect, but has little influence on PROGESTERONE ETHISTERONE PRANON£ LUTOCYLOL the structure of the endometrium. The progesterone preparation of choice is that dissolved in oil rather than in aqueous solution.…”
Section: Uses In Menstrual Abnormalitiesmentioning
confidence: 99%
“…I N THE PAST THREE YEARS testosterone propionate has been used extensively in the treatment of functional gynecologic conditions (1)(2)(3)(4)(5)(6)(7)(8)(9). This paper is a report of 10 cases of functional meno-metrorrhagia, treated with synthetic androgen (testosterone propionate), in which the therapeutic results were evidence of the usefulness of the male hormone in functional bleeding.…”
mentioning
confidence: 99%